Takeda IP Suit Over Hikma Gout Flare Drug Is Reopened
A Delaware federal judge has reopened Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing five patents through competing gout flare drug Mitigare, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article